Wasatch Advisors

Wasatch Advisors is an investment management company specializing in equity funds. The company manages institutional and individual portfolios. The company was formed in 1975 by Sam Stewart and still follows his philosophy of a bottom-up research method that focuses on long-term growth and finding market inefficiencies. Wasatch Advisors maintains its headquarters at Salt Lake City, Utah.
SR

Steven Rung

Director of Communications

22 past transactions

Incipient

Series E in 2008
Develops enterprise-class storage, SAN storage virtualization and automated data migration software solutions

Orexigen Therapeutics

Series C in 2006
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.

Johnnie-O, Inc.

Venture Round in 2022
Johnnie-O, Inc. designs and sells apparel for men, women, and children. It offers polos, button-downs, bottoms, T-shirts, outerwear, swimwear, and accessories. The company sells its products through stores in the United States, as well as offers products online. Johnnie-O, Inc. was founded in 2005 and is based in Santa Monica, California.

Inteliquent, Inc.

Series C in 2006
Inteliquent has an established tandem network that makes it easier, more efficient and cost-effective for wireless carriers, cable companies, CLECs and broadband service providers to enter new markets and grow existing business. As a leading provider of tandem services for carriers and service providers, Inteliquent's network infrastructure: * Improves the reliability of the Public Switched Telephone Network (PSTN), by providing tandem switch diversity * Reduces competitive tensions between carriers * Provides a cost-effective alternative to the incumbent tandem networks * Offers IP-based interconnection services along with traditional TDM services

Metro Optix

Series C in 2001
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

TherOx

Venture Round in 2005
TherOx, Inc. develops and manufactures dissolved oxygen delivery systems to improve the standard of care in heart attack treatments. It provides SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge and Console that controls cartridge operation wherein SSO2 solution is created and mixed with the patients blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded in 1994 and is based in Irvine, California. As of June 18, 2019, TherOx, Inc. operates as a subsidiary of ZOLL Medical Corporation.

Verticore Technologies

Series B in 2000
Verticore Technologies have been developing applications to improve the way organizations use and manage their knowledge and work processes. Leveraging this extensive experience, in June 1998 they launched the development of a unique framework designed to facilitate the rapid creation of a suite of browser-based applications to manage work processes and knowledge, and improve employee productivity. The framework addressed such critical factors as improved scorekeeping, clear goals, frequent feedback, participation, choice, and collaborative environments.

Medallia

Series F in 2019
Medallia helps companies win through customer and employee experience. It offers a SaaS platform that captures experience data from signal fields emitted by customers and employees. The platform utilizes AI technology to analyze structured and unstructured data from these signal fields across human, digital, and internet of things, or IoT, interactions. Using Medallia Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment. The company was founded in 2001 and is headquartered in San Francisco, California.

Tethys BioScience

Series D in 2009
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

BlueArc

Venture Round in 2006
BlueArc is a leading provider of high performance unified network storage systems to enterprise markets, as well as data intensive markets, such as electronic discovery, entertainment, federal government, higher education, Internet services, oil and gas and life sciences. Their products support both network attached storage, or NAS, and storage area network, or SAN, services on a converged network storage platform. Aquired by HDS as of September 7th 2011.

Fluidigm

Series E in 2007
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Orqis Medical

Series D in 2007
ORQIS Medical Corporation operates as a medical device company. It develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. It offers Cancion System, a heart failure treatment that uses continuous aortic flow augmentation technology to improve symptoms of heart failure and change the underlying course of the disease for patients hospitalized for de-compensated heart failure. The company’s products also include Exeleras System to treat chronic heart failure patients.

Metro Optix

Series B in 2000
Metro-Optix develops hardware for telecommunications companies that want to transition from circuit-based services to cell- and packet-based services. The hardware essentially reduces the number of hardware boxes needed, such as routers, which the networks feed into.

Ocera Therapeutics

Series C in 2008
Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety and efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward.

DataStax, Inc.

Series E in 2014
DataStax is the company behind the massively scalable, highly available, cloud-native NoSQL data platform built on Apache Cassandra™. DataStax gives users and enterprises the freedom to run data in any cloud on a global scale with zero downtime and zero lock-ins. More than 450 of the world’s leading enterprises including Capital One, Cisco, Comcast, Delta Airlines, eBay, Macy’s, McDonald’s, Safeway, Sony, and Walmart use DataStax to build transformational data architectures for real-world outcomes.

Ophthonix

Series C in 2005
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products through practitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California.

Incipient

Series D in 2006
Develops enterprise-class storage, SAN storage virtualization and automated data migration software solutions

Nanosys

Series C in 2005
Nanosys, Inc. develops and delivers quantum dot technology for high definition viewing experience for the display industry. It offers Quantum Dot Concentrate material; quantum dot nanomaterials; and Quantum Dot Enhancement film to industrial supply chain partners. Its products are used in tablets, televisions, smartphones, and other consumer electronics applications. Nanosys, Inc. was incorporated in 2001 and is based in Milpitas, California.

BlueArc

Series D in 2003
BlueArc is a leading provider of high performance unified network storage systems to enterprise markets, as well as data intensive markets, such as electronic discovery, entertainment, federal government, higher education, Internet services, oil and gas and life sciences. Their products support both network attached storage, or NAS, and storage area network, or SAN, services on a converged network storage platform. Aquired by HDS as of September 7th 2011.

DocuSign

Series F in 2015
DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

Quess Corp Limited

Venture Round in 2016
Quess Corp Ltd., India’s largest business services provider established in 2007. Headquartered in Bengaluru, the company has over 1,10,000 employees, serves over 1500 customers across 8 countries in more than 8000 locations. It has presence across 5 segments namely, Global Technology Solutions Group, Industrial Asset Management Group, Integrated Facilities Management Group, People Services & Logistics Group and Growth Businesses Group.